Directorate Change

RNS Number : 7657W
Tate & Lyle PLC
28 April 2021
 

28 April 2021

 

Tate & Lyle PLC

 

 

BOARD CHANGES

 

Tate & Lyle PLC (the "Company") announces that Patrícia Corsi will join the Board as a non-executive director and as a member of the Remuneration and Nominations Committees on 1 May 2021.

 

Patrícia is currently Global Chief Marketing & Digital Officer of Bayer Consumer Health, and has built a career spanning 20 years in global consumer products. She has served as SVP and Chief Marketing Officer, Mexico for Heineken NV and held various global brand roles for Unilever as well as marketing roles for Kraft Foods and Tetra Pak International in Brazil. 

 

Dr Gerry Murphy, Chair of Tate & Lyle, said: "I am delighted that Patrícia has agreed to join the Board. She brings experience of our key growth markets in Latin America as well as marketing, digital and brand expertise all of which will be of significant benefit to the Board."

 

As previously announced on 25 March 2021, non-executive director and Chair of the Remuneration Committee, Anne Minto will retire from the Board at the AGM on 29 July 2021 and non-executive director, Sybella Stanley, will succeed Anne as Chair of the Remuneration Committee from the conclusion of the AGM.

 

There are no further disclosures to be made in connection with Ms Corsi's appointment pursuant to paragraph 9.6.13 of the Financial Conduct Authority's Listing Rules.

 

 

END

 

For more information contact

Nick Hasell, FTI Consulting (Media)
Tel: Mobile: +44 (0) 7825 523 383


Christopher Marsh, VP, Investor Relations
chris.marsh@tateandlyle.com / +44 (0) 7796 192 688

 

About Tate & Lyle:  

Tate & Lyle PLC is a leading global provider of food and beverage ingredients and solutions.  Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fibre fortification, our Food & Beverage Solutions business develops solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings.  Our Primary Products business produces nutritive sweeteners, industrial starches used in paper and packaging, acidulants and products used for animal nutrition.

We have around 4,200 employees working in more than 60 locations across 30 countries. Tate & Lyle's purpose is Improving Lives for Generations and through our purpose we believe we can successfully grow our business and have a positive impact on society.  We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle sales totalled £2.9 billion.  For more information, please visit  http://www.tateandlyle.com  or follow Tate & Lyle on  Twitter  or  Linkedin .

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASEWFLWEFSEDL

Companies

Tate & Lyle (TATE)
UK 100

Latest directors dealings